Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Endocrinology
•
Pituitary Disorders
•
Adrenal Disorders
How do you approach monitoring for autoimmune disorders in patients with surgical remission of Cushing’s disease, given the higher incidence of autoimmune disease in this population?
PMID:
38373302
Related Questions
Should oral combined contraceptives be held prior to overnight dexamethasone suppression test to rule out Cushings?
Is a significant rise in cortisol post cosyntropin stimulation sufficient to rule out adrenal insufficiency in patients with low albumin?
Given the new 2022 WHO classification of pituitary tumors, should we be regularly counseling our patients about the risk of malignancy for what we previously referred to as pituitary adenomas but now classified as pituitary neuroendocrine tumors (PitNETs)?
What is the role of copeptin in the diagnosis of AVP deficiency (aka central diabetes insipidus)?
Can combined oral contraceptive use cause falsely elevated 24-hour urine-free cortisol?
Is there any indication for obtaining adrenal imaging in patients with MEN2 who have normal plasma or urinary metanephrines?
When and how do you taper off cabergoline therapy for treatment of microprolactinoma?
In adult women with NCCAH, is there a benefit in using supratherapeutic doses of prednisone in addition to clomiphene to improve fertility rates?
Should we be using a cut off of 20 rather than the traditional 10 Hounsfield units to distinguish between benign and malignant adrenocortical tumors on imaging?
In your practice, when do you opt to treat unilateral primary hyperaldosteronism medically rather than surgically?
